Chi Wai So

12PUBLICATIONS
47CO-AUTHORS
Nanoscale characterisationHaematological tumoursMolecular targetsHaematologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 08, 2026
Site-specific N6-methyladenosine fine tunes CTCF/cohesin-defined enhancer-promoter interactions and oncogenic transcription program.

|Mar 11, 2026
The transposable element-PARP axis underpins synthetic lethality and immunogenic vulnerability in blood cancer.

Bernd B Zeisig, Mohammad M Karimi, Chi Wai Eric So

|Jun 25, 2025
Transposable elements as novel therapeutic targets for PARPi-induced synthetic lethality in PcG-mutated blood cancer.

Bernd B Zeisig, Chiou-Tsun Tsai, Clemence Virely

|Apr 18, 2024
The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia.

Hannah Lawson, James P Holt-Martyn, Vilma Dembitz

|Jan 11, 2024
Hematopoietic stem cell quiescence and DNA replication dynamics maintained by the resilient β-catenin/Hoxa9/Prmt1 axis.

Jennifer Lynch, Estelle Troadec, Tsz Kan Fung

|Sep 22, 2023
Inhibition of PLK4 remodels histone methylation and activates the immune response via the cGAS-STING pathway in TP53-mutated AML.

Cheuk-Him Man, Wing Lam, Chee-Chean Dang

Pageof 2

Frequent Collaborators

3 joint publications

Anskar Yu-Hung Leung

3 joint publications

Suming Huang

2 joint publications

Bernd B Zeisig

2 joint publications

Claire Lynn